Neko
A better health check
About Neko
Neko Health is a Swedish health-tech company co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek. Neko's vision is to create a healthcare system that can help people stay healthy through preventive measures and early detection. This requires completely reimagining the patient's experience and incorporating the latest advances in sensors and AI.
Pitch deck breakdown
How Neko would pitch themselves.
Target customer
Business teams looking for modern saas tooling — replacing legacy software or building net-new workflows in this category.
Problem they solve
Neko Health is a Swedish health-tech company co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek. Neko's vision is to create a healthcare system that can help people stay healthy through preventive measures and early d… The category has historically been served by tools that miss the modern workflow this product is built around.
Key differentiator
Neko differentiates on a better health check. $0 raised — the company has resources + validation to compound this thesis.
Go-to-market strategy
Growth-stage GTM — multi-channel revenue motion (direct enterprise sales, channel partnerships, marketplace listings). Vertical specialisation + verticalised AE teams targeting enterprise + mid-market.
Neko website preview
Company facts
- Category
- SaaS
- Funding stage
- Series B
- Total raised
- $0
- Founded
- 2020
- Team size
- 201–500
- HQ
- Stockholm, Sweden
- Country
- Sweden
- Website
- nekohealth.com
Frequently asked questions
What does Neko do?
Neko Health is a Swedish health-tech company co-founded in 2018 by Hjalmar Nilsonne and Daniel Ek. Neko's vision is to create a healthcare system that can help people stay healthy through preventive measures and early detection. This requires completely reimagining the patient's experience and incorporating the latest advances in sensors and AI.
Where is Neko based?
Neko is based in Stockholm, Sweden, Sweden.
When was Neko founded?
Neko was founded in 2020.
How much has Neko raised?
Neko has raised $0 in their Series B round.